A carregar...

Priorities for developing respiratory syncytial virus vaccines in different target populations

The development of an effective vaccine against respiratory syncytial virus (RSV) has been hampered by major difficulties that occurred in the 1960s when a formalin-inactivated vaccine led to increased severity of RSV disease after acquisition of the virus in the RSV season after vaccination. Recent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Transl Med
Main Authors: Drysdale, Simon B., Barr, Rachael S., Rollier, Christine S., Green, Christopher A., Pollard, Andrew J., Sande, Charles J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613568/
https://ncbi.nlm.nih.gov/pubmed/32188721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aax2466
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!